|
Melanotan (other) , a drug originally developed as a skin tanning agent, but subsequently investigated as a potential treatment for sexual dysfunction
{{set index article ...
Melanotan may refer to one of two separate peptides: * Afamelanotide, originally developed under the names "Melanotan", "Melanotan-1", or "Melanotan I" for skin tanning, a drug currently available for prescription for certain light related skin indications and also in trials in implant form as a prophylactic treatment for a series of light affected skin disorders and potential skin cancer preventative agent * Melanotan II Melanotan II is a synthetic analogue of the peptide hormone α-melanocyte-stimulating hormone (α-MSH) that stimulates melanogenesis and increases sexual arousal. It was under development as drug candidate for female sexual dysfunction and ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Afamelanotide
Afamelanotide, sold under the brand name Scenesse, is a synthetic peptide and analogue of α-melanocyte stimulating hormone. It has been used to prevent skin damage from the sun in people with erythropoietic protoporphyria in the European Union since January 2015 and the United States since October 2019. As a medication, it is administered in subcutaneous implant form. Each implant lasts two months. The U.S. Food and Drug Administration (FDA) considers it to be a first-in-class medication. Medical use Afamelanotide is used in the European Union to prevent phototoxicity in adults with erythropoietic protoporphyria (EPP). For updates seEMA Index page/ref> Adverse effects Very common (may affect more than 10% of people) adverse effects in people with EPP include headache and nausea. Common (between 1% and 10%) adverse effects include back pain, upper respiratory tract infections, decreased appetite, migraine, dizziness, weakness, fatigue, lethargy, sleepiness, feeling hot, st ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |